|
|
| D-003 / CNRS (0 Trials) |
|
| D-0120 / InventisBio (0 Trials) |
|
| D-0502 / InventisBio (0 Trials) |
|
| D-0751 / InventisBio (0 Trials) |
|
| D-1553 / InventisBio (0 Trials) |
|
| D-4517.2 / Ashvattha Therap (0 Trials) |
|
| D-473 / Tonix (0 Trials) |
|
| D-512 / Wayne State University, Binghamton University, Michael J. Fox Foundation (0 Trials) |
|
| D-64406 / Friedrich-Schiller University of Jena (0 Trials) |
|
| D-65476 / Friedrich-Schiller University of Jena (0 Trials) |
|
| d-amphetamine transdermal drug delivery system (d-ATS) / Takeda (0 Trials) |
|
| D-cycloserine (JNX4022) / Junaxo (0 Trials) |
|
| D-galactose (AVTX-801) / Avalo Therap (0 Trials) |
|
| D-mannose (AVTX-802) / Avalo Therap (0 Trials) |
|
| D-penicillamine / Generic mfg. (0 Trials) |
|
| D-praziquantel / Sun Pharma (0 Trials) |
|
| D1-AAT / Kamada, Takeda (0 Trials) |
|
| D2C7 / Istari Oncology (0 Trials) |
|
| D3L-001 / D3 Bio (0 Trials) |
|
| D3L-002 / D3 Bio (0 Trials) |
|
| D3S-001 / D3 Bio (0 Trials) |
|
| D3S-002 / D3 Bio (0 Trials) |
|
| D3S-003 / D3 Bio (0 Trials) |
|
| D46/NS2/N/ΔM2-2-HindIII / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| D5-KRM-II-81 / RespireRx (0 Trials) |
|
| D6-B483 / Ashvattha Therap (0 Trials) |
|
| D9 / University of Michigan, Central China Normal University (0 Trials) |
|
| DA 3051 (interferon beta-1a biosimilar) / Dong-A (0 Trials) |
|
| DA 3111 (trastuzumab biosimilar) / Meiji Seika, Dong-A (0 Trials) |
|
| DA 3607 / Dong-A (0 Trials) |
|
| DA 9805 / Dong-A (0 Trials) |
|
| DA-1241 / Dong-A (0 Trials) |
|
| DA-2811 / Dong-A (0 Trials) |
|
| DA-3003 (sustained-release hGH) / Dong-A (0 Trials) |
|
| DA-3803 (choriogonadotropin alfa biosimilar) / Dong-A (0 Trials) |
|
| DA-3808 (factor VIII biosimilar) / Dong-A (0 Trials) |
|
| DA-3880 (darbepoetin alfa biosimilar) / Noritsu Koki, Dong-A, Medca Japan (0 Trials) |
|
| DA-4507 / Dong-A (0 Trials) |
|
| DA-5202 / Dong-A (0 Trials) |
|
| DA-5204 / Dong-A (1 Trials) |
|
| DA-7310 / Dong-A (0 Trials) |
|
| DA8010 / Dong-A (0 Trials) |
|
| DAAOI-P / China Medical University Hospital (0 Trials) |
|
| dabigatran etexilate / Generic mfg. (52 Trials) |
|
| dabigatran etexilate mesylate oral suspension (WD-1602) / Shanghai Fudan-Zhangjiang, China NT Pharma (0 Trials) |
|
| DAC HIV / ConjuChem (0 Trials) |
|
| dacarbazine / Generic mfg. (65 Trials) |
|
| dacetuzumab (SGN-40) / Seagen (0 Trials) |
|
| dach-platin polymeric micelle (Debio-0507) / NanoCarrier, Debiopharm (1 Trials) |
|
| daclatasvir/sofosbuvir / Generic mfg. (0 Trials) |
|
| DACRA-042 / Eli Lilly, Nordic Biosci (0 Trials) |
|
| DACRA-089 / Eli Lilly, Nordic Biosci (0 Trials) |
|
| dactinomycin / Generic mfg. (19 Trials) |
|
| dactolisib (RTB101) / Adicet Bio (3 Trials) |
|
| Daflon (micronized purified flavonoid fraction) / Servier (3 Trials) |
|
| daglutril (KC 12615) / Abbott, AbbVie (0 Trials) |
|
| Daklinza (daclatasvir) / BMS (6 Trials) |
|
| dalantercept (ACE-041) / Merck (MSD) (0 Trials) |
|
| dalargin (leu-enkephalin) / Burnasyan Federal Medical & Biophysical Center (0 Trials) |
|
| dalazatide (ShK-186) / Kineta, KPI Therap (0 Trials) |
|
| dalcetrapib (JTT-705) / DalCor (0 Trials) |
|
| dalcinonacog alfa (CB2679d) / ISU Abxis, GC Biopharma (0 Trials) |
|
| daleuton oral (DS107 oral) / DS Biopharma (1 Trials) |
|
| dalfampridine / Generic mfg. (21 Trials) |
|
| Dalibra (adalimumab biosimilar) / Biocad (0 Trials) |
|
| Daliresp (roflumilast) / AstraZeneca, Takeda, AbbVie (19 Trials) |
|
| dalnicastobart (LVGN7409) / Lyvgen (0 Trials) |
|
| dalotuzumab (MK 0646) / Merck (MSD), Pierre Fabre (0 Trials) |
|
| dalutrafusp alfa (AGEN1423) / Agenus (0 Trials) |
|
| DAN-222 / Dantari (0 Trials) |
|
| DAN-311 / Dantari (0 Trials) |
|
| danavorexton (TAK-925) / Takeda (1 Trials) |
|
| danazol oral / Generic mfg. (17 Trials) |
|
| danazol vaginal cream / FemmePharma, Covis Pharma (0 Trials) |
|
| danegaptide (ZP1609) / Zealand Pharma (0 Trials) |
|
| danicamtiv (MYK-491) / BMS (0 Trials) |
|
| danicopan (ALXN2040) / AstraZeneca (8 Trials) |
|
| danirixin (GSK1325756) / GSK (0 Trials) |
|
| Danshen Plus (radix salviae miltiorrhizae) / Tasly (4 Trials) |
|
| dantrolene / Generic mfg. (0 Trials) |
|
| danuglipron (PF-06882961) / Pfizer (0 Trials) |
|
| danusertib (PHA-739358) / Nerviano Medical Sciences (0 Trials) |
|
| danvatirsen (AZD9150) / AstraZeneca, Flamingo Therapeutics (6 Trials) |
|
| Danyelza (naxitamab) / Y-mAbs Therap (0 Trials) |
|
| dapagliflozin/linagliptin (IN-C009) / Korea Kolmar (0 Trials) |
|
| dapagliflozin/metformin (HCP1801) / Hanmi (0 Trials) |
|
| dapagliflozin/olmesartan medoxomil (ATB-101) / Autotelic, Jeil (0 Trials) |
|
| dapagliflozin/semaglutide (NN9917) / Novo Nordisk (0 Trials) |
|
| dapagliflozin/sitagliptin / AstraZeneca (0 Trials) |
|
| dapagliflozin/sitagliptin (DW6012) / Dong Wha (0 Trials) |
|
| dapagliflozin/sitagliptin (SID1903) / SK Bio (0 Trials) |
|
| dapansutrile (OLT1177) / Olatec Therap (4 Trials) |
|
| dapansutrile topical (OLT1177 gel) / Olatec Therap (0 Trials) |
|
| dapatifagene navolactibac (AG013) / Oragenics (0 Trials) |
|
| dapiglutide (ZP7570) / Zealand Pharma (0 Trials) |
|
| dapirolizumab pegol (CDP7657) / Biogen, UCB, Nektar Therap (3 Trials) |
|
| Dapivirine Vaginal Ring (dapivirine) / International Partnership for Microbicides, J&J (0 Trials) |
|
| daporinad (APO866) / Onxeo (0 Trials) |
|
| dapsone / Generic mfg. (8 Trials) |
|
| dapsone (PULM-001) / Pulmonem (0 Trials) |
|
| Daptacel (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) / Sanofi (0 Trials) |
|
| DAR 100 / DarPharma (0 Trials) |
|
| Darba (darbepoetin alfa biosimilar) / RPG Life Sci (0 Trials) |
|
| Darbatitor (darbepoetin alfa biosimilar) / Torrent Pharma (0 Trials) |
|
| darbepoetin alfa (NuPIAO) / 3SBio (0 Trials) |
|
| darbepoetin alfa biosimilar / Novavax (0 Trials) |
|
| darbepoetin alfa biosimilar / Kyowa Kirin (0 Trials) |
|
| Darbepoetin Alfa BS (darbepoetin alfa biosimilar) / JCR Pharma, Kissei (0 Trials) |
|
| DARE-1 / Bugworks (0 Trials) |
|
| Daren (emedastine) / Kowa, Merck (MSD) (1 Trials) |
|
| darexaban maleate (YM150) / Astellas (0 Trials) |
|
| Dargen (darbepoetin alfa biosimilar) / Lupin (0 Trials) |
|
| dargistotug (M6223) / EMD Serono (0 Trials) |
|
| DARIC33 / 2seventy bio (0 Trials) |
|
| DARIC33 Next-Gen / 2seventy bio (0 Trials) |
|
| darigabat (CVL-865) / Cerevel Therap (3 Trials) |
|
| Dark Antigen based cancer vaccine / Enara Bio, Boehringer Ingelheim (0 Trials) |
|
| darleukin (L19-IL2 fusion protein) / Philogen (5 Trials) |
|
| darotropium bromide (GSK233705) / GSK (0 Trials) |
|
| darovasertib (IDE196) / Ideaya Biosci (1 Trials) |
|
| DARPin-conjugated radioligand therapeutic / Novartis, Molecular Partners (0 Trials) |
|
| darTregs / National Institute of Allergy and Infectious Diseases (4 Trials) |
|
| darunavir/ritonavir / Generic mfg. (0 Trials) |
|
| darusentan (HMR-4005) / Gilead (4 Trials) |
|
| Darzalex (daratumumab) / J&J (133 Trials) |
|
| Darzalex Faspro (daratumumab/hyaluronidase) / J&J (7 Trials) |
|
| dasatinib / Generic mfg. (108 Trials) |
|
| DasKloster 0112-01 / Relief Therap (0 Trials) |
|
| dasolampanel (NGX-426) / Horizon Therapeutics (0 Trials) |
|
| dasotraline (SEP-225289) / Sumitomo Dainippon (0 Trials) |
|
| Dasynoc (dasatinib amorphous) / Xspray Pharma (0 Trials) |
|
| datelliptium (NSC311152) / Sanofi (0 Trials) |
|
| datopotamab deruxtecan (DS-1062a) / Daiichi Sankyo, AstraZeneca (0 Trials) |
|
| daunorubicin / Generic mfg. (147 Trials) |
|
| DaunoXome (liposomal daunorubicin) / SOBI, Galen (0 Trials) |
|
| Daurismo (glasdegib) / Pfizer (10 Trials) |
|
| DAV0601 / Avicenna Pharma (0 Trials) |
|
| DAV132 / Da Volterra (0 Trials) |
|
| davalintide (AC2307) / BMS (0 Trials) |
|
| Davanat (galactomannan) / Galectin Therap (1 Trials) |
|
| Davictrel (etanercept biosimilar) / Hanwha Chem (0 Trials) |
|
| davoceticept (ALPN-202) / Alpine Immune Sci (0 Trials) |
|
| davunetide intranasal (AL-108) / Endo (0 Trials) |
|
| DAW1033B2 / Brigham and Womens Hospital (0 Trials) |
|
| DAW2020 / Brigham and Womens Hospital (0 Trials) |
|
| daxdilimab (HZN-7734) / Horizon Therapeutics (6 Trials) |
|
| Daxxify (daxibotulinumtoxinA) / Revance Therap (1 Trials) |
|
| Daybue (trofinetide) / Neuren, Acadia Pharma (2 Trials) |
|
| Daytrana (methylphenidate transdermal system) / Hisamitsu (4 Trials) |
|
| Dayvigo (lemborexant) / Eisai (0 Trials) |
|
| dazodalibep (HZN-4920) / Horizon Therapeutics (3 Trials) |
|
| dazucorilant (CORT113176) / Corcept Therap (0 Trials) |
|
| DB-1303 / DualityBio (0 Trials) |
|
| DB-1305 / DualityBio (0 Trials) |
|
| DB001 / DotBio (0 Trials) |
|
| DB002 / DotBio (0 Trials) |
|
| DB003 / DotBio (0 Trials) |
|
| DB004 / DotBio (0 Trials) |
|
| DB105 / Denovo, J&J (0 Trials) |
|
| DB200 program / Midatech (0 Trials) |
|
| DB818 / Tokyo Medical and Dental University (0 Trials) |
|
| dBET6 / Dana-Farber Cancer Institute (0 Trials) |
|
| DBI-002 / DermBiont (0 Trials) |
|
| DBPR108 / CSPC Pharma (0 Trials) |
|
| DC Bead (E7040) / Eisai, Boston Scientific (3 Trials) |
|
| DC Vaccine / Diakonos Research (0 Trials) |
|
| DC vaccine for prostate cancer / Medigene, Oslo University Hospital (0 Trials) |
|
| DC-006 vaccine / Oslo University Hospital (0 Trials) |
|
| DC-1-192 / Cardiff University School of Medicine (0 Trials) |
|
| DC-806 / DICE Therapeutics (0 Trials) |
|
| DC-AdGMCAIX / Gilead (0 Trials) |
|
| DC-CIK / Hornetcorn Biotech (5 Trials) |
|
| DC-CIK immune cell therapy / Bohui Biotech, National Taiwan University Hospital (0 Trials) |
|
| DC-TAB / Delta Crystallon (0 Trials) |
|
| DC-U4106 / China Pharmaceutical University, Chinese Academy of Sciences (0 Trials) |
|
| DC101 / Eli Lilly (0 Trials) |
|
| DC8E8 / Axon Neurosci (0 Trials) |
|
| DC9703 / Obio Pharmaceutical (0 Trials) |
|
| DCB-HDG2-411 / Development Center for Biotechnology (0 Trials) |
|
| DCBY02 / DynamiCure Biotech (0 Trials) |
|
| DCC-2157 / Deciphera (0 Trials) |
|
| DCC-2721 / Deciphera (0 Trials) |
|
| DCC-3084 / Deciphera (0 Trials) |
|
| DCC-3116 / Deciphera (0 Trials) |
|
| DCCCyB / Merck (MSD) (0 Trials) |
|
| dCellVax / Regen BioPharma (0 Trials) |
|
| DCIKKb / ICVS Tokyo Clinic, Hasumi International Research Foundation (0 Trials) |
|
| DCLL9718S / Roche (0 Trials) |
|
| DCP-001 / Mendus (2 Trials) |
|
| DCR-AUD / Novo Nordisk (0 Trials) |
|
| DCR-COMP1 / AstraZeneca, Novo Nordisk (0 Trials) |
|
| DCR-COMP2 / AstraZeneca, Novo Nordisk (0 Trials) |
|
| DCR-MYC / Novo Nordisk (0 Trials) |
|
| DCR-PH1 / Novo Nordisk (0 Trials) |
|
| DCSZ11 / DynamiCure Biotech (0 Trials) |
|
| DCVAC/Dia / Sotio (0 Trials) |
|
| DCVAC/LuCa / Sotio (0 Trials) |
|
| DCVAC/OvCa / Sotio (3 Trials) |
|
| DCVax-Direct / Northwest Biotherap (0 Trials) |
|
| DCVax-L (autologous dendritic cell vaccine leaded with autologous tumor cell lysate) / Northwest Biotherap (2 Trials) |
|
|